Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab
Authors
Keywords
-
Journal
EYE
Volume 25, Issue 6, Pages 661-672
Publisher
Springer Nature
Online
2011-04-01
DOI
10.1038/eye.2011.66
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage
- (2010) Sebastian Thaler et al. ACTA OPHTHALMOLOGICA
- Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated in the MARINA and ANCHOR Trials
- (2010) Irene A. Barbazetto et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab
- (2010) K. Matsuyama et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Intracellular bevacizumab reduces phagocytotic uptake in RPE cells
- (2010) Alexa Klettner et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- VEGF Antagonists Decrease Barrier Function of Retinal Pigment Epithelium In Vitro: Possible Participation of Intracellular Glutathione
- (2010) Y. Miura et al. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
- In Vitro Effects of Antivascular Endothelial Growth Factors on Cultured Human Trabecular Meshwork Cells
- (2010) Malik Y. Kahook et al. JOURNAL OF GLAUCOMA
- Lack of Therapeutic Effect of Ranibizumab in Fellow Eyes After Intravitreal Administration
- (2010) Maria-Andreea Gamulescu et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Effects of Bevacizumab on Apoptosis, Na+-K+-Adenosine Triphosphatase and Zonula Occludens 1 Expression on Cultured Corneal Endothelial Cells
- (2010) Efdal Yoeruek et al. OPHTHALMIC RESEARCH
- Qualitätsunterschiede zwischen Ranibizumab aus Originalbehältern und aus Fertigspritzen
- (2010) S. Grisanti et al. OPHTHALMOLOGE
- AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF PEGAPTANIB OR RANIBIZUMAB IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
- (2010) Osamu Sawada et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Early loss of pregnancy after intravitreal bevacizumab injection
- (2009) Petros Petrou et al. ACTA OPHTHALMOLOGICA
- In vitroevaluation of bevacizumab toxicity on a retinal ganglion cell line
- (2009) Rajesh K. Sharma et al. ACTA OPHTHALMOLOGICA
- Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
- (2009) Manju L. Subramanian et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study
- (2009) K E Schmid-Kubista et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Duration of action of intravitreal ranibizumab and bevacizumab in exudative AMD eyes based on macular volume measurements
- (2009) A R Shah et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical safety of ranibizumab in age-related macular degeneration
- (2009) Ursula Schmidt-Erfurth Expert Opinion On Drug Safety
- Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells
- (2009) Alexa Karina Klettner et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Bevacizumab and ranibizumab on microvascular endothelial cells: A comparative study
- (2009) Raquel Costa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Evaluation of Differential Toxicity of Varying Doses of Bevacizumab on Retinal Ganglion Cells, Retinal Pigment Epithelial Cells, and Vascular Endothelial Growth Factor–Enriched Choroidal Endothelial Cells
- (2009) Vikram S. Brar et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- The Effect of Intravitreal Ranibizumab on the Fellow Untreated Eye with Subfoveal Scarring due to Exudative Age-Related Macular Degeneration
- (2009) Alexandros Rouvas et al. OPHTHALMOLOGICA
- A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
- (2009) David S. Boyer et al. OPHTHALMOLOGY
- Effects of Intraocular Ranibizumab and Bevacizumab in Transgenic Mice Expressing Human Vascular Endothelial Growth Factor
- (2009) Katsuaki Miki et al. OPHTHALMOLOGY
- Neovascular Age-related Macular Degeneration: Intraocular Cytokines and Growth Factors and the Influence of Therapy with Ranibizumab
- (2009) Marion Funk et al. OPHTHALMOLOGY
- THE EFFECT OF UNILATERAL INTRAVITREAL BEVACIZUMAB (AVASTIN), IN THE TREATMENT OF DIFFUSE BILATERAL DIABETIC MACULAR EDEMA
- (2009) RAUL VELEZ-MONTOYA et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- SHORT-TERM EFFECTIVENESS OF INTRAVITREAL BEVACIZUMAB VERSUS RANIBIZUMAB INJECTIONS FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2009) TOM S. CHANG et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2009) KIMBERLY E. STEPIEN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAVITREAL INJECTION OF 2.5 mg VERSUS 1.25 mg BEVACIZUMAB (AVASTIN) FOR TREATMENT OF CNV ASSOCIATED WITH AMD
- (2009) MEHDI MODARRES et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- BEVACIZUMAB IS NOT TOXIC TO RETINAL GANGLION CELLS AFTER REPEATED INTRAVITREAL INJECTION
- (2009) CHENG-KUO CHENG et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Rapid progression of subclinical age-related macular degeneration in the untreated fellow eye after intravitreal bevacizumab
- (2008) Young Hee Yoon et al. ACTA OPHTHALMOLOGICA
- Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
- (2008) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results
- (2008) Andrew N. Antoszyk et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Effect of Bevacizumab on Inflammation and Proliferation in Human Choroidal Neovascularization
- (2008) Olcay Tatar ARCHIVES OF OPHTHALMOLOGY
- VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells
- (2008) H Deissler et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors
- (2008) Jian-Feng Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization
- (2008) Young Sang Han et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab
- (2008) Osamu Sawada et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- VEGF Inhibition and Renal Thrombotic Microangiopathy
- (2008) Vera Eremina et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Macular Degeneration
- (2008) Rama D. Jager et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization
- (2008) Qi Zhu et al. OPHTHALMOLOGY
- Pharmacokinetics
- (2008) Suk Ho Byeon et al. OPHTHALMOLOGY
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- CHANGES IN AQUEOUS VASCULAR ENDOTHELIAL GROWTH FACTOR AND PIGMENT EPITHELIAL-DERIVED FACTOR LEVELS FOLLOWING INTRAVITREAL BEVACIZUMAB INJECTIONS FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION OR PATHOLOGIC MYOPIA
- (2008) WAI-MAN CHAN et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More